Skip to main content
Results 1 - 1 of 1
Sort Results By:
Orphan Drugs: Commercialization, Clinical and Regulatory Challenges
Published Date: May 17, 2011
Gerson Lehrman Group Inc.'s panel of experts discusses the commercial, clinical, and regulatory challenges unique to orphan drug development.
gerson lehrman group
Get your company's research in the hands of targeted business professionals.